PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28365794-0	2017	Response: Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.	Esomeprazole	82-94	cholecystokinin B receptor	Homo sapiens	54-67	
27796466-0	2017	Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.	Esomeprazole	72-84	cholecystokinin B receptor	Homo sapiens	44-57	
23179899-1	2013	YF476 differs from the proton pump inhibitor (PPI) esomeprazole in mode of action by antagonizing the type 2 receptor of cholecystokinin/gastrin (CCK-2R).	Esomeprazole	51-63	cholecystokinin B receptor	Homo sapiens	146-152